110 related articles for article (PubMed ID: 2471903)
1. The antitumor intercalating drug ditercalinium binds preferentially to RNA in Friend erythroleukemia cells.
Traganos F; Bueti C; Kapuscinski J; Darzynkiewicz Z
Leukemia; 1989 Jul; 3(7):522-9. PubMed ID: 2471903
[TBL] [Abstract][Full Text] [Related]
2. Cytokinetic effects of bifunctional antitumor intercalator ditercalinium on Friend erythroleukemia cells.
Traganos F; Bueti C; Melamed MR; Darzynkiewicz Z
Leukemia; 1987 May; 1(5):411-6. PubMed ID: 3478539
[TBL] [Abstract][Full Text] [Related]
3. Denaturation and condensation of DNA in situ induced by acridine orange in relation to chromatin changes during growth and differentiation of Friend erythroleukemia cells.
Darzynkiewicz Z; Traganos F; Kapuscinski J; Melamed MR
Cytometry; 1985 May; 6(3):195-207. PubMed ID: 3858089
[TBL] [Abstract][Full Text] [Related]
4. Cytostatic and cytotoxic properties of pyronin Y: relation to mitochondrial localization of the dye and its interaction with RNA.
Darzynkiewicz Z; Kapuscinski J; Carter SP; Schmid FA; Melamed MR
Cancer Res; 1986 Nov; 46(11):5760-6. PubMed ID: 2428484
[TBL] [Abstract][Full Text] [Related]
5. Tight binding of the antitumor drug ditercalinium to quadruplex DNA.
Carrasco C; Rosu F; Gabelica V; Houssier C; De Pauw E; Garbay-Jaureguiberry C; Roques B; Wilson WD; Chaires JB; Waring MJ; Bailly C
Chembiochem; 2002 Dec; 3(12):1235-41. PubMed ID: 12465032
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric analysis of RNA content in different cell populations using pyronin Y and methyl green.
Pollack A; Prudhomme DL; Greenstein DB; Irvin GL; Claflin AJ; Block NL
Cytometry; 1982 Jul; 3(1):28-35. PubMed ID: 6180873
[TBL] [Abstract][Full Text] [Related]
7. Selective loss of mitochondrial DNA after treatment of cells with ditercalinium (NSC 335153), an antitumor bis-intercalating agent.
Segal-Bendirdjian E; Coulaud D; Roques BP; Le Pecq JB
Cancer Res; 1988 Sep; 48(17):4982-92. PubMed ID: 2842043
[TBL] [Abstract][Full Text] [Related]
8. Interactions of antitumor drug ditercalinium with nucleic acids in solutions and in situ.
Kapuscinski J; Traganos F; Darzynkiewicz Z
Cancer Lett; 1988 Nov; 42(3):185-91. PubMed ID: 3191470
[TBL] [Abstract][Full Text] [Related]
9. De-intercalation of ethidium bromide and acridine orange by xanthine derivatives and their modulatory effect on anticancer agents: a study of DNA-directed toxicity enlightened by time correlated single photon counting.
Johnson IM; Kumar SG; Malathi R
J Biomol Struct Dyn; 2003 Apr; 20(5):677-86. PubMed ID: 12643770
[TBL] [Abstract][Full Text] [Related]
10. Recognition by the DNA repair system of DNA structural alterations induced by reversible drug-DNA interactions.
Lambert B; Segal-Bendirdjian E; Esnault C; Le Pecq JB; Roques BP; Jones B; Yeung AT
Anticancer Drug Des; 1990 Feb; 5(1):43-53. PubMed ID: 2180423
[TBL] [Abstract][Full Text] [Related]
11. Effects of the bifunctional antitumor intercalator ditercalinium on DNA in mouse leukemia L1210 cells and DNA topoisomerase II.
Markovits J; Pommier Y; Mattern MR; Esnault C; Roques BP; Le Pecq JB; Kohn KW
Cancer Res; 1986 Nov; 46(11):5821-6. PubMed ID: 3019538
[TBL] [Abstract][Full Text] [Related]
12. Effects of new antitumor bifunctional intercalators derived from 7H-pyridocarbazole on sensitive and resistant L 1210 cells.
Esnault C; Roques BP; Jacquemin-Sablon A; Le Pecq JB
Cancer Res; 1984 Oct; 44(10):4355-60. PubMed ID: 6467197
[TBL] [Abstract][Full Text] [Related]
13. Action of dihydroxyanthraquinone on cell cycle progression and survival of a variety of cultured mammalian cells.
Traganos F; Evenson DP; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
Cancer Res; 1980 Mar; 40(3):671-81. PubMed ID: 6162553
[TBL] [Abstract][Full Text] [Related]
14. Staining with pyronin Y detects changes in conformation of RNA during mitosis and hyperthermia of CHO cells.
Traganos F; Crissman HA; Darzynkiewicz Z
Exp Cell Res; 1988 Dec; 179(2):535-44. PubMed ID: 2461311
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric estimation of DNA and RNA content in intact cells stained with Hoechst 33342 and pyronin Y.
Shapiro HM
Cytometry; 1981 Nov; 2(3):143-50. PubMed ID: 6170496
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of bisimidazoacridones, new drugs with potent, selective activity against colon cancer.
Hernandez L; Cholody WM; Hudson EA; Resau JH; Pauly G; Michejda CJ
Cancer Res; 1995 Jun; 55(11):2338-45. PubMed ID: 7757985
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the size and position of substituents on 7H-pyrido[4,3-c]carbazole monomers and dimers and their DNA binding and anti-tumor properties.
Léon P; Garbay-Jaureguiberry C; Le Pecq JB; Roques BP
Anticancer Drug Des; 1988 Jun; 3(1):1-13. PubMed ID: 3382504
[TBL] [Abstract][Full Text] [Related]
18. Intracellular binding sites of acridine orange in living osteosarcoma cells.
Kusuzaki K; Murata H; Takeshita H; Hashiguchi S; Nozaki T; Emoto K; Ashihara T; Hirasawa Y
Anticancer Res; 2000; 20(2A):971-5. PubMed ID: 10810383
[TBL] [Abstract][Full Text] [Related]
19. Application of pyronin Y(G) in cytochemistry of nucleic acids.
Darzynkiewicz Z; Kapuscinski J; Traganos F; Crissman HA
Cytometry; 1987 Mar; 8(2):138-45. PubMed ID: 2438101
[TBL] [Abstract][Full Text] [Related]
20. Denaturation of nucleic acids induced by intercalating agents. Biochemical and biophysical properties of acridine orange-DNA complexes.
Kapuscinski J; Darzynkiewicz Z
J Biomol Struct Dyn; 1984 Jun; 1(6):1485-99. PubMed ID: 6400830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
